Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-aminoimidazole ribonucleoside
- Development stage
- Unknown
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
5-Aminoimidazole ribonucleoside is a synthetic or naturally occurring nucleoside in which a beta-D-ribofuranose sugar is N-linked to the imidazole ring at position 1, with an amino group at position 5 of the imidazole. It belongs to the class of imidazole ribonucleosides and is structurally related to intermediates in purine biosynthesis. The compound can be used experimentally as an exogenous source for cellular purine and thiamine requirements, as it can enter metabolic pathways leading to nucleotide and vitamin synthesis[1][2]. Its primary use has been in research settings rather than clinical medicine.
- Other names
- CHEBI:142416
02
Targets
ThiD (Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase)Nucleotide synth (Nucleotide synthesis enzymes)
Beyond the preview
Go deeper on 5-aminoimidazole ribonucleoside.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-aminoimidazole ribonucleoside.